Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2336)	4/14/2008 11:39:28 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MSHL was up 10% on low volume of 55,886, but which was > its ADV.<g> bigcharts.marketwatch.com It presented again data at the AACR on Saturday, showing that its drug candidate triphendiol (NV-196) induces apoptosis in pancreatic & bile duct cancer cell lines, & retards tumor proliferation in animal models of both indications. As previously mentioned, the stock needs to close above $3.08 in order to get off the DT coming from its Nov 12 spike to $3.98 bigcharts.marketwatch.com Bernard